Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 119

1.

Neonatal pneumonia in sub-Saharan Africa.

Green RJ, Kolberg JM.

Pneumonia (Nathan). 2016 Apr 12;8:3. doi: 10.1186/s41479-016-0003-0. eCollection 2016. Review.

2.

Mesonia hippocampi sp. nov., isolated from the brood pouch of a diseased Barbour's Seahorse (Hippocampus barbouri).

Kolberg J, Busse HJ, Wilke T, Schubert P, Kämpfer P, Glaeser SP.

Int J Syst Evol Microbiol. 2015 Jul;65(7):2241-7. doi: 10.1099/ijs.0.000245. Epub 2015 Apr 10.

PMID:
25862387
3.

Human antibody responses to pneumococcal surface protein A and capsular polysaccharides during acute and convalescent stages of invasive disease in adult patients.

Kolberg J, Aase A, Naess LM, Aaberge IS, Caugant DA.

Pathog Dis. 2014 Feb;70(1):40-50. doi: 10.1111/2049-632X.12106. Epub 2013 Nov 21.

PMID:
24151210
4.

Performance of a multi-marker diabetes risk score in the Insulin Resistance Atherosclerosis Study (IRAS), a multi-ethnic US cohort.

Rowe MW, Bergman RN, Wagenknecht LE, Kolberg JA.

Diabetes Metab Res Rev. 2012 Sep;28(6):519-26. doi: 10.1002/dmrr.2305.

5.

Biomarker models as surrogates for the disposition index in the Insulin Resistance Atherosclerosis Study.

Watkins SM, Rowe MW, Kolberg JA, Wagenknecht LE, Bergman RN.

Diabet Med. 2012 Nov;29(11):1399-406. doi: 10.1111/j.1464-5491.2012.03625.x.

6.

Validation of a multi-marker model for the prediction of incident type 2 diabetes mellitus: combined results of the Inter99 and Botnia studies.

Lyssenko V, Jørgensen T, Gerwien RW, Hansen T, Rowe MW, McKenna MP, Kolberg J, Pedersen O, Borch-Johnsen K, Groop L.

Diab Vasc Dis Res. 2012 Jan;9(1):59-67. doi: 10.1177/1479164111424762. Epub 2011 Nov 4.

PMID:
22058089
7.

Biomarkers in Type 2 diabetes: improving risk stratification with the PreDx ® Diabetes Risk Score.

Kolberg JA, Gerwien RW, Watkins SM, Wuestehube LJ, Urdea M.

Expert Rev Mol Diagn. 2011 Nov;11(8):775-92. doi: 10.1586/erm.11.63.

PMID:
22022939
8.

Comparison of accuracy of diabetes risk score and components of the metabolic syndrome in assessing risk of incident type 2 diabetes in Inter99 cohort.

Shafizadeh TB, Moler EJ, Kolberg JA, Nguyen UT, Hansen T, Jorgensen T, Pedersen O, Borch-Johnsen K.

PLoS One. 2011;6(7):e22863. doi: 10.1371/journal.pone.0022863. Epub 2011 Jul 29.

9.

Cost-effectiveness of risk stratification for preventing type 2 diabetes using a multi-marker diabetes risk score.

Sullivan SD, Garrison LP Jr, Rinde H, Kolberg J, Moler EJ.

J Med Econ. 2011;14(5):609-16. doi: 10.3111/13696998.2011.602160. Epub 2011 Jul 11.

PMID:
21740291
10.

Polyreactivity of monoclonal antibodies made against human erythrocyte membranes with various pathogenic bacteria.

Kolberg J, Ihle Ø, Thiede B, Aase A.

Hybridoma (Larchmt). 2011 Feb;30(1):1-9. doi: 10.1089/hyb.2010.0062.

PMID:
21466280
11.

Biomarkers in fasting serum to estimate glucose tolerance, insulin sensitivity, and insulin secretion.

Goldfine AB, Gerwien RW, Kolberg JA, O'Shea S, Hamren S, Hein GP, Xu XM, Patti ME.

Clin Chem. 2011 Feb;57(2):326-37. doi: 10.1373/clinchem.2010.156133. Epub 2010 Dec 13.

12.

Validation of a multimarker model for assessing risk of type 2 diabetes from a five-year prospective study of 6784 Danish people (Inter99).

Urdea M, Kolberg J, Wilber J, Gerwien R, Moler E, Rowe M, Jorgensen P, Hansen T, Pedersen O, Jørgensen T, Borch-Johnsen K.

J Diabetes Sci Technol. 2009 Jul 1;3(4):748-55.

13.

Development of a type 2 diabetes risk model from a panel of serum biomarkers from the Inter99 cohort.

Kolberg JA, Jørgensen T, Gerwien RW, Hamren S, McKenna MP, Moler E, Rowe MW, Urdea MS, Xu XM, Hansen T, Pedersen O, Borch-Johnsen K.

Diabetes Care. 2009 Jul;32(7):1207-12. doi: 10.2337/dc08-1935.

14.

Peptide mimics of two pneumococcal capsular polysaccharide serotypes (6B and 9V) protect mice from a lethal challenge with Streptococcus pneumoniae.

Smith CM, Lo Passo C, Scuderi A, Kolberg J, Baxendale H, Goldblatt D, Oggioni MR, Felici F, Andrew PW.

Eur J Immunol. 2009 Jun;39(6):1527-35. doi: 10.1002/eji.200839091.

15.

The surface-associated elongation factor Tu is concealed for antibody binding on viable pneumococci and meningococci.

Kolberg J, Hammerschmidt S, Frank R, Jonák J, Sanderová H, Aase A.

FEMS Immunol Med Microbiol. 2008 Jul;53(2):222-30. doi: 10.1111/j.1574-695X.2008.00419.x. Epub 2008 May 5.

16.

Specificity of subcapsular antibody responses in Ethiopian patients following disease caused by serogroup A meningococci.

Norheim G, Aseffa A, Yassin MA, Mengistu G, Kassu A, Fikremariam D, Tamire W, Merid Y, Høiby EA, Caugant DA, Fritzsønn E, Tangen T, Melak B, Berhanu D, Harboe M, Kolberg J, Rosenqvist E.

Clin Vaccine Immunol. 2008 May;15(5):863-71. doi: 10.1128/CVI.00252-07. Epub 2008 Mar 12.

17.

Streptococcus pneumoniae enolase is important for plasminogen binding despite low abundance of enolase protein on the bacterial cell surface.

Kolberg J, Aase A, Bergmann S, Herstad TK, Rødal G, Frank R, Rohde M, Hammerschmidt S.

Microbiology. 2006 May;152(Pt 5):1307-17.

PMID:
16622048
18.

Nuclear and plasma membrane localization of SH3BP4 in retinal pigment epithelial cells.

Khanobdee K, Kolberg JB, Dunlevy JR.

Mol Vis. 2004 Dec 13;10:933-42.

20.

Epitope mapping of pneumococcal surface protein A of strain Rx1 using monoclonal antibodies and molecular structure modelling.

Kolberg J, Aase A, Rødal G, Littlejohn JE, Jedrzejas MJ.

FEMS Immunol Med Microbiol. 2003 Dec 5;39(3):265-73.

21.

Binding properties and anti-bacterial activities of V-region identical, human IgG and IgM antibodies, against group B Neisseria meningitidis.

Michaelsen TE, Ihle Ø, Beckstrøm KJ, Herstad TK, Sandin RH, Kolberg J, Aase A.

Biochem Soc Trans. 2003 Oct;31(Pt 5):1032-5.

PMID:
14505474
22.
23.

OligoDesign: Optimal design of LNA (locked nucleic acid) oligonucleotide capture probes for gene expression profiling.

Tolstrup N, Nielsen PS, Kolberg JG, Frankel AM, Vissing H, Kauppinen S.

Nucleic Acids Res. 2003 Jul 1;31(13):3758-62.

24.

Sustained high proportion of zidovudine-resistant HIV variants despite prolonged substitution of zidovudine by other nucleoside reverse transcriptase inhibitors.

Bélec L, Legoff J, Si-Mohamed A, Andréoletti L, Mbopi-Kéou FX, Kolberg J, Matta M, Detmer J, Piketty C, Kazatchkine MD.

J Med Virol. 2002 Sep;68(1):1-6.

PMID:
12210423
25.
26.

Cross-reactive polyclonal antibodies to the inner core of lipopolysaccharide from Neisseria meningitidis.

Andersen SR, Guthrie T, Guile GR, Kolberg J, Hou S, Hyland L, Wong SY.

Infect Immun. 2002 Mar;70(3):1293-300.

27.

Epitope analyses of pneumococcal surface protein A: a combination of two monoclonal antibodies detects 94% of clinical isolates.

Kolberg J, Aase A, Michaelsen TE, Rødal G.

FEMS Immunol Med Microbiol. 2001 Oct;31(3):175-80.

28.

Analysis of the expression of the putatively virulence-associated neisserial protein RmpM (class 4) in commensal Neisseria and Moraxella catarrhalis strains.

Troncoso G, Sánchez S, Kolberg J, Rosenqvist E, Veiga M, Ferreirós CM, Criado M.

FEMS Microbiol Lett. 2001 May 30;199(2):171-6.

29.

Single-copy gene detection using branched DNA (bDNA) in situ hybridization.

Player AN, Shen LP, Kenny D, Antao VP, Kolberg JA.

J Histochem Cytochem. 2001 May;49(5):603-12.

PMID:
11304798
30.

PorB3 outer membrane protein on Neisseria meningitidis is poorly accessible for antibody binding on live bacteria.

Michaelsen TE, Aase A, Kolberg J, Wedge E, Rosenqvist E.

Vaccine. 2001 Jan 8;19(11-12):1526-33.

PMID:
11163678
31.

Streptococcus pneumoniae heat shock protein 70 does not induce human antibody responses during infection.

Kolberg J, Høiby EA, Aase A, Sletten K, Rødal G, Michaelsen TE, Bucher A.

FEMS Immunol Med Microbiol. 2000 Dec;29(4):289-94.

32.
33.

Direct mecA detection from blood culture bottles by branched-DNA signal amplification.

Zheng X, Kolbert CP, Varga-Delmore P, Arruda J, Lewis M, Kolberg J, Cockerill FR, Persing DH.

J Clin Microbiol. 1999 Dec;37(12):4192-3.

34.

Hepatitis G virus and human immunodeficiency virus coinfection: response to interferon-alpha therapy.

Lau DT, Miller KD, Detmer J, Kolberg J, Herpin B, Metcalf JA, Davey RT, Hoofnagle JH.

J Infect Dis. 1999 Oct;180(4):1334-7.

PMID:
10479167
35.

The clinical significance of simultaneous infection with hepatitis G virus in patients with chronic hepatitis C.

Brandhagen DJ, Gross JB Jr, Poterucha JJ, Charlton MR, Detmer J, Kolberg J, Gossard AA, Batts KP, Kim WR, Germer JJ, Wiesner RH, Persing DH.

Am J Gastroenterol. 1999 Apr;94(4):1000-5.

PMID:
10201473
36.

Functional activities and epitope specificity of human and murine antibodies against the class 4 outer membrane protein (Rmp) of Neisseria meningitidis.

Rosenqvist E, Musacchio A, Aase A, Høiby EA, Namork E, Kolberg J, Wedege E, Delvig A, Dalseg R, Michaelsen TE, Tommassen J.

Infect Immun. 1999 Mar;67(3):1267-76.

37.

Preparation of genotype-specific HCV RNA transcripts for assessing HCV detection and quantification assays.

Detmer JJ, Kolberg JA, Zayati CL, Collins ML.

Methods Mol Med. 1999;19:99-111. doi: 10.1385/0-89603-521-2:99.

PMID:
21374352
38.

Quantitation of progesterone receptor mRNA in breast carcinoma by branched DNA assay.

Nargessi RD, Shimizu RM, Xu XM, Connolly J, Zamroud M, Collins ML, Kolberg J.

Breast Cancer Res Treat. 1998 Jul;50(1):57-62.

PMID:
9802620
39.

Quantitation of estrogen receptor mRNA in breast carcinoma by branched DNA assay.

Nargessi RD, Khabbaz NF, Xu XM, Zamroud M, Kolberg J, Collins ML.

Breast Cancer Res Treat. 1998 Jul;50(1):47-55.

PMID:
9802619
40.

Hepatitis after liver transplantation: the role of the known and unknown viruses.

Pessoa MG, Terrault NA, Ferrell LD, Detmer J, Kolberg J, Collins ML, Viele M, Lake JR, Roberts JP, Ascher NL, Wright TL.

Liver Transpl Surg. 1998 Nov;4(6):461-8.

41.

Quantification of cytokine mRNA in peripheral blood mononuclear cells using branched DNA (bDNA) technology.

Shen LP, Sheridan P, Cao WW, Dailey PJ, Salazar-Gonzalez JF, Breen EC, Fahey JL, Urdea MS, Kolberg JA.

J Immunol Methods. 1998 Jun 1;215(1-2):123-34.

PMID:
9744754
42.

Direct quantitation of HIV by flow cytometry using branched DNA signal amplification.

Van Cleve M, Ostrerova N, Tietgen K, Cao W, Chang C, Collins ML, Kolberg J, Urdea M, Lohman K.

Mol Cell Probes. 1998 Aug;12(4):243-7.

PMID:
9727202
43.

Branched-DNA assay for detection of the mecA gene in oxacillin-resistant and oxacillin-sensitive staphylococci.

Kolbert CP, Arruda J, Varga-Delmore P, Zheng X, Lewis M, Kolberg J, Persing DH.

J Clin Microbiol. 1998 Sep;36(9):2640-4.

44.
45.

Genotypic changes in human immunodeficiency virus type 1 associated with loss of suppression of plasma viral RNA levels in subjects treated with ritonavir (Norvir) monotherapy.

Eastman PS, Mittler J, Kelso R, Gee C, Boyer E, Kolberg J, Urdea M, Leonard JM, Norbeck DW, Mo H, Markowitz M.

J Virol. 1998 Jun;72(6):5154-64.

46.

Quantitation of hepatitis G and C viruses in the liver: evidence that hepatitis G virus is not hepatotropic.

Pessoa MG, Terrault NA, Detmer J, Kolberg J, Collins M, Hassoba HM, Wright TL.

Hepatology. 1998 Mar;27(3):877-80.

PMID:
9500722
47.

Sequence diversity, predicted two-dimensional protein structure, and epitope mapping of neisserial Opa proteins.

Malorny B, Morelli G, Kusecek B, Kolberg J, Achtman M.

J Bacteriol. 1998 Mar;180(5):1323-30.

48.

Hepatitis G virus infection in patients transplanted for cryptogenic cirrhosis: red flag or red herring?

Charlton MR, Brandhagen D, Wiesner RH, Gross JB Jr, Detmer J, Collins M, Kolberg J, Krom RA, Persing DH.

Transplantation. 1998 Jan 15;65(1):73-6.

PMID:
9448147
49.

Activation of tumor necrosis factor-alpha system in chronic hepatitis C virus infection.

Nelson DR, Lim HL, Marousis CG, Fang JW, Davis GL, Shen L, Urdea MS, Kolberg JA, Lau JY.

Dig Dis Sci. 1997 Dec;42(12):2487-94.

PMID:
9440625
50.

Hepatitis C and G co-infection: response to interferon therapy and quantitative changes in serum HGV-RNA.

McHutchison JG, Nainan OV, Alter MJ, Sedghi-Vaziri A, Detmer J, Collins M, Kolberg J.

Hepatology. 1997 Nov;26(5):1322-7.

PMID:
9362379

Supplemental Content

Loading ...
Support Center